# BEPOTASTINE BESILATE
> **ANDA214588** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2023-04-05
## Drug
- **FDA Application Number:** ANDA214588
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BEPOTASTINE BESILATE
- **Generic name:** BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5%
- **Active ingredients:** BEPOTASTINE BESILATE
- **Dosage form:** SOLUTION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Limited
- **First approval:** 2023-04-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214588)
---
*AI Analytics · CC0 1.0*